PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

Treatment of arterial hypertension (AH) despite the large variety of antihypertensive drugs currently remains one of the most urgent problems in modern cardiology. However, the scheme used in clinical practice does not always correspond to existing recommendations, in particular, of the European Soc...

Bibliográfalaš dieđut
Váldodahkkit:	N. A. Morina, O. D. Savkova, E. A. Fedorova, I. L. Tsarev, A. B. Frolkova, A. E. Tsygankova, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
Materiálatiipa:	Artihkal
Giella:	Russian
Almmustuhtton:	Remedium Group LLC 2017-11-01
Ráidu:	Медицинский совет
Fáttát:	arterial hypertension cardiovascular complications antihypertensive therapy angiotensin converting enzyme inhibitors renin-angiotensin-aldosterone system blockers slow calcium channel blockers
Liŋkkat:	https://www.med-sovet.pro/jour/article/view/2007

Geahča maid

Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients
Dahkki: Annina S. Vischer, et al.
Almmustuhtton: (2021-03-01)

Role of antihypertensive medicines in prostate cancer: a systematic review
Dahkki: Chinonyerem O. Iheanacho, et al.
Almmustuhtton: (2024-04-01)

Blood Pressure Control and Antihypertensive Treatment among Hemodialysis Patients—Retrospective Single Center Experience
Dahkki: Piotr Skonieczny, et al.
Almmustuhtton: (2021-06-01)

Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies
Dahkki: Yang Zhao, et al.
Almmustuhtton: (2018-01-01)

The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
Dahkki: Piotr Jędrusik, et al.
Almmustuhtton: (2021-05-01)

Mechanisms of food protein-derived antihypertensive peptides other than ACE inhibition
Dahkki: Chibuike C. Udenigwe, et al.
Almmustuhtton: (2014-05-01)

Prescription pattern and effectiveness of antihypertensive drugs in patients with aortic dissection who underwent surgery
Dahkki: Kuang-Ming Liao, et al.
Almmustuhtton: (2023-11-01)

Renin-angiotensin-aldosterone system blockers as the main pathogenetic approach of drug nephroprotection
Dahkki: N.D. Filipets, et al.
Almmustuhtton: (2019-02-01)

Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
Dahkki: Jordan Loader, et al.
Almmustuhtton: (2022-06-01)

Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic
Dahkki: Simon B. Gressens, et al.
Almmustuhtton: (2021-02-01)

Renin-angiotensin system blockers and COVID-19
Dahkki: Emmanuelle Vidal-Petiot, et al.
Almmustuhtton: (2021-06-01)

Angiotensins and rheumatoid arthritis
Dahkki: N. M. Savushkina, et al.
Almmustuhtton: (2019-01-01)

The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study
Dahkki: José Luño, et al.
Almmustuhtton: (2017-07-01)

Association between types of antihypertensive medication and the risk of atrial fibrillation: a nationwide population study
Dahkki: JungMin Choi, et al.
Almmustuhtton: (2024-05-01)

Association of Cardiovascular Medications With Adverse Outcomes in a Matched Analysis of a National Cohort of Patients With COVID-19
Dahkki: Leonard K. Wang, et al.
Almmustuhtton: (2023-06-01)

Assessment of Anti-Hypertensive Drug Adherence by Serial Aldosterone-To-Renin Ratio Measurement
Dahkki: Fabrizio Buffolo, et al.
Almmustuhtton: (2021-05-01)

Prospects of using genetic testing to increase the effectiveness of antihypertensive therapy
Dahkki: N. V. Drobotya, et al.
Almmustuhtton: (2020-06-01)

Effect of different single and combined antihypertensive drug regimens on the mortality of critical care patients
Dahkki: Yipeng Fang, et al.
Almmustuhtton: (2024-08-01)

Treatment of proteinuria in dogs with telmisartan: A retrospective study
Dahkki: Julie Lecavalier, et al.
Almmustuhtton: (2021-07-01)

Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study
Dahkki: Jenny I. Shen, et al.
Almmustuhtton: (2017-06-01)

Research Progress on Antihypertensive Effect of Polysaccharide and Its Mechanism
Dahkki: Jilong XU, et al.
Almmustuhtton: (2023-02-01)

Antihypertensive therapy in patients with arterial hypertension and concomitant diseases in real clinical practice (according to the National Registry of Arterial Hypertension, 2019–2022)
Dahkki: Anna V. Aksenova, et al.
Almmustuhtton: (2024-10-01)

INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?
Dahkki: S. V. Stolov
Almmustuhtton: (2020-12-01)

Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke
Dahkki: Konstantinos Tziomalos, et al.
Almmustuhtton: (2017-04-01)

Sartans in the treatment of high-risk hypertension: the abilities of candesartan
Dahkki: T E Morozova
Almmustuhtton: (2013-06-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
Dahkki: K. A. Ghyamdzhyan, et al.
Almmustuhtton: (2022-12-01)

The renin–angiotensin–aldosterone-system and right heart failure in congenital heart disease
Dahkki: Stine Andersen, et al.
Almmustuhtton: (2016-06-01)

Effect of ACEi and ARBs vs Non ACEi/ARBs in Hypertension with Respect to Renal Outcomes in COVID-19 Infection: A Retrospective Cohort Study
Dahkki: S Ravitej, et al.
Almmustuhtton: (2022-11-01)

Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization
Dahkki: Hye-Jin Park, et al.
Almmustuhtton: (2022-01-01)

Perspectives of using angiotensin receptor antagonists
Dahkki: V V Fomin
Almmustuhtton: (2009-06-01)

Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network
Dahkki: Steven M. Smith, et al.
Almmustuhtton: (2023-01-01)

Hypertension, medications, and risk of severe COVID‐19: A Massachusetts community‐based observational study
Dahkki: Ann Z. Bauer, et al.
Almmustuhtton: (2021-01-01)

A high sodium intake reduces antiproteinuric response to renin–angiotensin–aldosterone system blockade in kidney transplant recipients
Dahkki: Elena Monfá, et al.
Almmustuhtton: (2016-09-01)

Early Rapid Decline in Kidney Function as a Beneficial Sign After Starting Antihypertensive Medication
Dahkki: Joachim Beige
Almmustuhtton: (2019-06-01)

The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer
Dahkki: José A. Carlos-Escalante, et al.
Almmustuhtton: (2021-05-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
Dahkki: Maksimov M.L., et al.
Almmustuhtton: (2017-02-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
Dahkki: M L Maksimov, et al.
Almmustuhtton: (2017-03-01)

Clinical pharmacogenetics of angiotensin II receptor blockers in Iraq
Dahkki: Hany A Al-Hussaniy, et al.
Almmustuhtton: (2023-01-01)

A Study of Morphological Changes in Renal Afferent Arterioles Induced by Angiotensin II Type 1 Receptor Blockers in Hypertensive Patients
Dahkki: Yohko Nagai, et al.
Almmustuhtton: (2020-01-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
Dahkki: M L Maksimov
Almmustuhtton: (2010-06-01)